W. L. Gore & Associates, Inc. ("Gore"), a global materials science company, recently announced the commercial launch of the 0 ...

Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Outlook Therapeutics introduces Lytenava in Germany & UK for the treatment of wet AMD: Iselin, New Jersey Tuesday, June 3, 2025, 16:00 Hrs [IST] Outlook Therapeutics, Inc., a biop ...

Hovanesian: The first diagnosis is a good time to refer, because GA patients lose visual acuity somewhat predictably, as much ...

The concern of endophthalmitis is casting a larger spector over the treatment of ocular conditions with intravitreal injection. Bevacizumab is typically obtained through such compounding ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Patients requiring frequent ranibizumab intravitreal injections for various indications as part of their routine clinical care were recruited to partake in this study. The primary goal of the ...

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...